Potentox reduces biochemical and inflammatory response in osteomyelitis infection

International Journal of Osteoporosis and Metabolic Disorders

Volumn 4, Issue 1, 2011, Pages 26-36

  Dwivedi, V K ^a   Soni, A ^a   Payasi, A ^a   Ahmad, A ^a   Singh, Shambhu P ^a   Chaudhary, M ^a  

^a Venus Medicine Research Centre   (India)

Author keywords

Biochemical parameters; Levofloxacin; Mda; Mpo; Osteomyelitis; Potentox

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIKACIN PLUS CEFEPIME; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CALCIUM; CREATININE; GLUTATHIONE; INTERLEUKIN 6; LEVOFLOXACIN; MALONALDEHYDE; MYELOPEROXIDASE; PHOSPHORUS; POTENTOX; PROTEIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; BODY TEMPERATURE MONITORING; BODY WEIGHT; CALCIUM BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; DRUG EFFICACY; DRUG SAFETY; KIDNEY FUNCTION TEST; LIPID PEROXIDATION; LIVER TOXICITY; METAPHYSIS; MORTALITY; NONHUMAN; OSTEOMYELITIS; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RAT; SODIUM BLOOD LEVEL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIBIA; TREATMENT DURATION; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 79956157411     PISSN: 19945442     EISSN: 20772157     Source Type: Journal    
DOI: 10.3923/ijom.2011.26.36     Document Type: Article

References (34)

1. Baumann, H. and J. Gauldie, 1994. The acute phase response. Immunol. Today, 15: 74-80.
2. Bramlage, L.R. and M.S. Dvm, 1998. Infection of bones and joints. AAEP., 44: 148-151.
3. Calandra, T., J. Gerain, D. Heumann, J. Baumgartner and D.M.P. Glauser, 1991. High circulating levels of interleukin-6 in patients with septic shock evolution during sepsis, prognostic value and interplay with other cytokines. the Swiss-Dutch J5 Immunoglobulin Study Group. Am. J. Med, 91:23-29.
4. Chang, I.H., Y.K. Wen and M.L. Chen, 2008. Glomerulonephritis with acute renal failure related to osteomyelitis. J. Chin. Med Assoc, 71: 315-317.
5. Chaudhary, M. and S.M. Shrivastava, 2006. Minimum inhibitory concentration of ceftriaxone and vancomycin in penicillin resistant Staphylococcus aureus, Entrococcus faecalis and Streptococcus pneumoniae. J. Natcon., 18: 177-180.
6. Chaudhary, M., A. Soni, V. Dwivedi and S.M. Shrivastava, 2008. Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculuc mice. Curr. Clin. Phamrcol, 3:211-214.
7. Dwivedi, V.K, A. Soni, M. Chaudhary, C.P. Singh and S.M. Shrivastava, 2009. Fixed dose combination of cefepime plus amikacin (potentox) inhibit pneumonia infection. Exp. Lung. Res., 35: 621-629.
8. Ersoz, G., B.N. Aytacoglu, N. Sucu, L. Tamer and I. Bayindir et al., 2006. Comparison and evaluation of experimental mediastinitis models precolonized foreign body implants and bacterial suspension inoculation seems promising. BMC Infect Dis., 25: 66-76.
9. Evans, C.A.W., J. Jellis, S.P.F. Hughes, D.G. Remick and J.S. Friedland, 1998. Tumor necrosis factor-a, interleukin-6 and interleukin-8 secretion and the acute phase response in patients with bacterial and tuberculous osteomyelitis. J. Infect. Dis., 177: 1582-1587.
10. Friedland, J., S. Suputtamongkol, Y.D.G. Remick, W. Chaowagul and R.M. Strieter et al., 1992. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicémie and localized Pseudomonas pseudomallei infection. Infect. Immun., 60: 2402-2408.
11. Garrett, I.R., B.F. Boyce, R.O. Oreffo, L. Bonewald, J. Poser and G.R. Mundy, 1990. Oxygen-derived free radicals stimulate osteoclastic bone résorption in rodent bone in vitro and in vivo. J. Clin. Invest, 85: 632-639.
12. Hack, C.E, M. Hart, R.J. van Schijndel, A.J. Eerenberg, J.H. Nuijens, L.G. Thijs and L.A. Aarden, 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect. Immun, 60: 2835-2842.
13. Hissin, P.J. and R.A. Hilf, 1976. Flourometric method for determination of oxidized and reduced glutathione in tissue. Anal. Biochem, 74: 214-26.
14. Horowitz, M.C. and J.A. Lorenzo, 1996. Local Regulators of Bone: IL-1, TNF, Lymphotoxin Interferon-g IL-8, IL-10, IL-4, the LIF/IL-6 Family and Additional Cytokines. In: Principles of Bone Biology, Bilezikian, J.P, L.G. Raisz and G.A. Rodan (Eds.). Academic Press, San Diego, pp: 687-700.
15. Jauregui, L, D. Matzke, M. Scott, P. Minnsa and G. Hageage, 1993. Cefepime as treatment for osteomyelitis and other severe bacterial infections. J. Antimicrobial Chemother, 32: 141-149.
16. Klosterhalfen, B, M. Peters, C. Tons, S. Hauptmann, CL. Klein and C.J. Kirkpatrick, 1996. Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J. Trauma, 40: 372-378.
17. Kopf, M, H. Baumann, G. Freer, M. Freudenberg and M. Lamers et al., 1994. Impaired immune and acute-phase responses in interleukin 6 deficient mice. Nature, 368: 339-342.
18. Korksuz, F, A. Uchida, Y. Shinto, N. Araki, K. Iaouf and K. Ono, 1993. Experimental implant-related osteomyelitis treated by antibiotic-calciu hydroxyapatite ceramic composites. J. Bone Joint Surg, 25: 111-114.
19. Kumar, V, A.K. Abbas, N. Fausto and R.N. Mitchell, 2007. Robbms Basic Pathology. 8th Edn, Saunders Elsevier, UK, pp: 810-811.
20. Kurutas, E.B., O. Arican and S. Sasmaz, 2005. Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris. Acta Dermatoven, 14: 39-42.
21. Lew, D.P. and F.Â. Waldvogel, 1997. Osteomyelitis. N. Engl. J. Med, 336: 999-1007.
22. Luca, L.J., T. Mader and J.H. Calhoun, 2004. Osteomyelitis in long bones. J. Bone Joint Surg Am., 86: 2305-2318.
23. Lucke, M., G. Schmidmaiera, S.S. Wildemanna, B. Wildemann, R. Schiller, N.B. Haas and M. Raschke 2003. Gentamicin coating of metallic implants reduces implant-related osteomyelitis m rats. Bone, 32: 521-531.
24. Marie, C, C. Fitting, C. Cheval, M.R. Losser and J. Carlet et al., 1997. Bresence of high levels of leukocyte- associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect. Immun., 65: 865-871.
25. Mathison, J., E.C. Wolfson and J. Ulevitch, 1988. Barticipation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest, 81: 1925-1937.
26. Murdoch, D.R, R.J. Everts, S.T. Chambers and I.A. Cowan, 1996. Vertebral osteomyelitis due to Staphylococcus lugdunensis. J. Clin. Microbiol, 34: 993-994.
27. Nicolau, D.P, L. Nie, B.R. Tessier and C.H. Nightingale, 1998. Brophylaxis of Acute osteomyelitis with absorbable ofloxacin-impregnated beads. Antimicrob. Agents. Chemother, 42: 840-842.
28. Ohkawa, H, N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem, 95: 351-358.
29. Perry, C.R. and R.L. Pearson, 1991. Local antibiotic delivery in the treatment of bone and joint infections. Clin. Orthop. Relat. Res, 263: 215-226.
30. Remick, D. and J.S. Friedland, 1997. Cytokines in Health and Disease. 2nd Edn, Marcel ekker, New York.
31. Rouse, M.S., K.E. Biper, Y. Khaliq, J.M. Steckelberg and R. Batel, 2001. Treatment of S. aureus experimental osteomyelitis with matrix III delivered amikacin or clindamycin. Antimicrob Agents Chemother, 41: 1145-1145.
32. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue and A.T. Lee et al., 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330: 662-664.
33. Waldvogel, F.A, G. Medoff and M.N. Swartz, 1970. Osteomyelitis a review of clinical features therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N. Engl. J. Med, 282: 316-322.
34. Yadav, V, S. Sharma, K. Harjai, H. Mohan and S. Chhibber, 2003. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiellapneumoniaein mice. Ind. J. Med. Res, 118:47-52.